Antagonizing action of chlorpromazine, dibenamine, and phenoxybenzamine on potassium-induced contraction.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D002127:Calcium Isotopes; D002746:Chlorpromazine / Q000494:pharmacology*; D003983:Dibenzylchlorethamine / Q000494:pharmacology*; D004336:Drug Antagonism; D004878:Ergotamine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D005730:Ganglionic Blockers / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D010643:Phenoxybenzamine / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology*; D011817:Rabbits; D013565:Sympatholytics / Q000494:pharmacology; D015016:Yohimbine / Q000494:pharmacology
D002127:Calcium Isotopes; D004983:Ethanolamines; D005730:Ganglionic Blockers; D013565:Sympatholytics; D010643:Phenoxybenzamine; D000804:Angiotensin II; D015016:Yohimbine; D003983:Dibenzylchlorethamine; D007545:Isoproterenol; D004878:Ergotamine; D011188:Potassium; D002118:Calcium; D002746:Chlorpromazine; D010646:Phentolamine